Literature DB >> 11545611

Human papilloma virus E6 and E7 proteins support DNA replication of adenoviruses deleted for the E1A and E1B genes.

D S Steinwaerder1, C A Carlson, A Lieber.   

Abstract

The action of transforming proteins from small DNA tumor viruses seems to be remarkably similar between different viruses, as they all use pRb and p53 pathways as cellular targets. This leads to deregulation of host cell cycling, which in turn creates an environment favorable for viral replication. Based on this, we hypothesized that regulatory proteins from human papillomaviruses (HPVs) can functionally trans-complement viral DNA replication of adenoviruses deleted for the E1A and E1B genes (AdE1-). To test this, we constructed AdE1- vectors expressing the human papilloma virus 16 (HPV-16) proteins E6 and E7. Expression of both E6 and E7 from these vectors partially complemented adenoviral DNA replication activity in vitro, in SK-Hep1 cells and primary human astrocytes, as well as in vivo in mouse liver. AdE1- vectors expressing E6 and E7 also increased hepatocellular DNA synthesis in vivo. Efficient AdE1- DNA replication was detected in HPV-associated cervical carcinoma cells but not in primary human cells. Linking the expression of regulatory oncoviral proteins to DNA replication of E1-mutant adenoviruses may provide a rationale for antitumor strategies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11545611     DOI: 10.1006/mthe.2001.0447

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  11 in total

1.  Host range of Kaposi's sarcoma-associated herpesvirus in cultured cells.

Authors:  Jill T Bechtel; Yuying Liang; Joshua Hvidding; Don Ganem
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

2.  Temozolomide renders murine cancer cells susceptible to oncolytic adenovirus replication and oncolysis.

Authors:  Rodolfo Garza-Morales; Kavitha Yaddanapudi; Rigoberto Perez-Hernandez; Eric Riedinger; Kelly M McMasters; Haval Shirwan; Esma Yolcu; Roberto Montes de Oca-Luna; Jorge G Gomez-Gutierrez
Journal:  Cancer Biol Ther       Date:  2018-01-22       Impact factor: 4.742

3.  Oncolytic adenoviruses targeted to Human Papilloma Virus-positive head and neck squamous cell carcinomas.

Authors:  Christopher J LaRocca; Joohee Han; Amanda O Salzwedel; Julia Davydova; Mark C Herzberg; Rajaram Gopalakrishnan; Masato Yamamoto
Journal:  Oral Oncol       Date:  2016-03-18       Impact factor: 5.337

4.  Adenoviral protein V promotes a process of viral assembly through nucleophosmin 1.

Authors:  Hideyo Ugai; George C Dobbins; Minghui Wang; Long P Le; David A Matthews; David T Curiel
Journal:  Virology       Date:  2012-06-18       Impact factor: 3.616

5.  Effect of adenovirus-mediated heat shock protein expression and oncolysis in combination with low-dose cyclophosphamide treatment on antitumor immune responses.

Authors:  Nelson C Di Paolo; Sebastian Tuve; Shaoheng Ni; Karl Erik Hellström; Ingegerd Hellström; André Lieber
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

6.  Adenovirus Lacking E1b Efficiently Induces Cytopathic Effect in HPV-16-Positive Murine Cancer Cells via Virus Replication and Apoptosis.

Authors:  Elvis Martinez-Jaramillo; Rodolfo Garza-Morales; Stephen L Wechman; Roberto Montes de Oca-Luna; Odila Saucedo-Cardenas; Haval Shirwan; Esma Yolcu; Kelly M McMasters; Jorge G Gomez-Gutierrez
Journal:  Cancer Invest       Date:  2018-02-01       Impact factor: 2.176

7.  A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication.

Authors:  Kathrin Bernt; Min Liang; Xun Ye; Shaoheng Ni; Zong-Yi Li; Sheng Long Ye; Fang Hu; André Lieber
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

8.  High-level expression by tissue/cancer-specific promoter with strict specificity using a single-adenoviral vector.

Authors:  Yumi Kanegae; Miho Terashima; Saki Kondo; Hiromitsu Fukuda; Aya Maekawa; Zheng Pei; Izumu Saito
Journal:  Nucleic Acids Res       Date:  2010-11-04       Impact factor: 16.971

9.  Attenuation of vaccinia Tian Tan strain by removal of viral TC7L-TK2L and TA35R genes.

Authors:  Shifu Kan; Yuhang Wang; Lili Sun; Peng Jia; Yanxin Qi; Jiaqiang Su; Lei Liu; Guohua Yang; Liming Liu; Zhuoyue Wang; Jinhui Wang; Guangchen Liu; Ningyi Jin; Xiao Li; Zhuang Ding
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

10.  Potent anti-tumor effects of a dual specific oncolytic adenovirus expressing apoptin in vitro and in vivo.

Authors:  Xiao Li; Yan Liu; Zhongmei Wen; Chang Li; Huijun Lu; Mingyao Tian; Kuoshi Jin; Lili Sun; Pegn Gao; Encheng Yang; Xiaohong Xu; Shifu Kan; Zhuoyue Wang; Yuhang Wang; Ningyi Jin
Journal:  Mol Cancer       Date:  2010-01-20       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.